Glicost MP 2mg/500mg/15mg Tablet ER
Marketer
Aronex Life Sciences Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glicost MP 2mg/500mg/15mg Tablet ER
Diabetic patients with type 2 mellitus may find their blood glucose management improved by using the extended-release combination medication, Glycotrol MP 2mg/500mg/15mg tablets. This medication, used alongside a balanced diet and regular exercise, facilitates better insulin utilization, leading to reduced blood sugar. Always adhere to your physician's prescribed dosage and regimen. Taking this medication with food minimizes potential stomach discomfort. If a dose is missed, take it promptly unless the next dose is imminent; in that case, skip the missed dose and resume your usual schedule. Never double the dose. Excessive intake can result in hypoglycemia (low blood sugar). Concomitant use with other antidiabetic drugs, alcohol, or skipped meals may increase the risk of hypoglycemia. Regular blood glucose monitoring is essential during treatment. Common adverse effects can include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, discuss any existing kidney, liver, or heart conditions with your doctor. Pregnant or lactating individuals should seek medical advice before use. Kidney function assessment will precede treatment initiation. Limit alcohol consumption as this can heighten the risk of side effects.
Primary Ingredients of Glicost MP 2mg/500mg/15mg Tablet ER
There is no text provided to rephrase.
Uses of Glicost MP 2mg/500mg/15mg Tablet ER
Managing type 2 diabetes
Major Benefits of Glicost MP 2mg/500mg/15mg Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or fracturing it. Glicost MP 2mg/500mg/15mg Extended-Release tablets should be administered with a meal.
Common Side effects of Glicost MP 2mg/500mg/15mg Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glicost MP 2mg/500mg/15mg Tablet ER:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Glicost MP 2mg/500mg/15mg Extended-Release tablets with food.
How Glicost MP 2mg/500mg/15mg Tablet ER works:
Glicost MP 2mg/500mg/15mg Extended-Release tablets contain glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. These medications employ diverse actions to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood sugar levels. Metformin, a biguanide, functions by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glicost MP 2mg/500mg/15mg Tablet ER with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glicost MP 2mg/500mg/15mg tablet might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glicost MP tablets (2mg/500mg/15mg) are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk with the possibility of infant harm.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyCAUTION
Patients with kidney impairment should use Glicost MP 2mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should use Glicost MP 2mg/500mg/15mg Extended-Release Tablets cautiously, as dose modification may be necessary. Physician consultation is advised. Glicost MP 2mg/500mg/15mg Extended-Release Tablets are contraindicated in patients with severe liver disease.
What if you forget to take Glicost MP 2mg/500mg/15mg Tablet ER :
Should you forget a dose of Glicost MP 2mg/500mg/15mg Extended-Release Tablet, take it promptly. However, near the time for your next scheduled dose, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Glicost MP 2mg/500mg/15mg Tablet ER
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Treatment | Medication for diabetes |
3,018 People bought this recently